The Effect Effect of Empagliflozin on Oxidative Stress in Patients With Type 2 Diabetes

NCT02890745 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

31

Enrollment

OTHER

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: Empagliflozin
DRUG: Placebo

Sponsor

Henrik Enghusen Poulsen

Collaborators

[object Object]
[object Object]